Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06985576
Long-term Study to Evaluate Safety and Persistence of GF-CART01
Sponsor: GenomeFrontier Therapeutics TW Co., Ltd.
View on ClinicalTrials.gov
Summary
The goal of this observational study is to learn about the long-term safety of GF-CART01 after cell infusion up to 15 years.
Official title: A Long-term Follow-up Study of GF-01-01 to Evaluate the Safety and Persistence of GF-CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
18
Start Date
2026-05
Completion Date
2041-05
Last Updated
2025-12-18
Healthy Volunteers
No
Conditions
Locations (1)
National Taiwan University Hospital
Taipei, Taiwan